Modest Progress at the Sixth Review Conference
Posted by Alan Pearson at 7:19 am on December 11, 2006
The experts will be assessing the outcome of the Sixth Review Conference of the Biological Weapons Convention (BWC) for weeks, months, even years to come. For now, having mulled over its Final Outcome document, I’ll stick with our assessment that the Conference is best described as a “modest success.”
Very modest.
That success might best be summed up as follows: the States Parties to the Convention will continue to have yearly meetings between now and the Seventh Review Conference in 2011. Which means that there may be some hope for progress after the Bush Administration finally departs in January 2009, if the American people decide to elect a President who will engage in, maybe even lead, real diplomacy to forge global responses to global threats.
Until then, we’ll have to muddle through as best we can. In the BWC context, that means States, intergovernmental organizations, and a wide range of non-state actors will have to find ways to take advantage of annual meetings and other opportunities created by the Review Conference to help advance bioweapons non-proliferation efforts. There will, of course, also be other opportunities outside of the BWC, perhaps most notably UN Secretary General Kofi Annan’s proposed UN Forum on biotechnology risks and benefits.
The opportunities within the BWC will regrettably be few, and it will be hard to take advantage of them. As expected, it is unlikely that there will be recurring topics, beyond universalization, at the annual meetings of States Parties. Thus, even though the obligations of States Parties to the BWC were enumerated in the Final Declaration, there may be little incentive for States Parties to put much effort into meeting these obligations.
Moreover, the States Parties failed to agree on an “action plan” to improve national implementation of their obligations under the BWC. This was due to deep divisions over the relationship between non-proliferation and peaceful cooperation (especially including technology transfer) that have plagued the BWC for the past twenty years. These divisions have only grown more acute as biotechnology has become increasingly important economically. The UN Forum will not be able to avoid this issue.
Having failed to agree on an action plan, the States Parties also failed to reaffirm some statements, agreed at the Fourth Review Conference and reasserted at the 2003 Meeting of States Parties, of what effective national implementation entails. For instance, they failed to assert that States Parties should review and update their national implementation measures to ensure that they remain effective, implying that national implementation is a one-off exercise that will be immune to any changes in the world. They failed to incorporate agreed-on recommendations of 2003 that national implementation should include “regulatory measures,” or that there be “comprehensive and concrete national measures to secure pathogen collections and … [to] control their use.”
Without the action plan and recurring topics, there is less work for the newly agreed upon 3-person Implementation Support Unit (ISU) to do. At least I was wrong about whether the ISU would be eliminated altogether. As it stands, ISU activities are limited to administrative support (including efforts to promote universalization of the Convention) and facilitating confidence building measure (CBM) submissions. That said, this includes “supporting, as appropriate, the implementation by the States Parties of the decisions and recommendations” of the Review Conference. The BioWeapons Prevention Project notes, optimistically, that this and other tasks “may allow some flexibility in the operation of the ISU … [all] might be subject to either a broad or narrow interpretation of the mandate.” Since some States Parties will watch the ISU closely to ensure that it does not overstep the mandate they feel it has been given, the ISU and its supporters will have to move carefully fulfill the BWPP’s optimistic hopes.
Meanwhile, the CBMs, which are really the only means currently available to the States Parties as a whole to demonstrate and assess compliance with the treaty, will not be strengthened. The United States successfully pushed a short-sighted “increase participation first” strategy. The CBMs were designed twenty years ago and their relevance to contemporary compliance concerns decreases with every year that they are not updated. It is hard to see what greater participation alone buys.
In fact, compliance itself suffers in the Final Declaration, which mentions the phrases “compliance” and “non-compliance” only half as often as does the Final Declaration of the Fourth Review Conference in 1996 (the Fifth Review Conference did not issue a Final Declaration). Of particular concern to me are two deletions. First, an appeal to “scientific communities to lend their support only to activities that have justification for prophylactic, protective and other peaceful purposes, and [to] refrain from undertaking or supporting activities which are in breach of the obligations deriving from provisions of the Convention” has inexplicably been removed. Second, the concept that “non-compliance should be treated with determination in all cases, without selectivity or discrimination,” has also been deleted.
The reasons for these deletions are not clear, especially in light of strong statements on the need to “confront non-compliance” that were made by the U.S. during the Review Conference. “Determination” is precisely what has been lacking in the BWC thus far, though I suppose an argument could be made for deleting a word simply on the basis that States Parties shouldn’t talk about things they aren’t willing to do. That doesn’t instill much confidence.
As for the deletion of “without selectivity and discrimination,” perhaps we should not be surprised. This is entirely consistent with current US non-proliferation policy, a central tenet of which is, as Michael Krepon notes in relation to US nuclear weapons policy
that the world remains divided, this time between responsible states— U.S. friends and allies—and evildoers. Because these two camps operate by very different rules, the Bush administration postulated and sought to enforce separate norms for each camp.” Thus, “[t]he Bush team has strongly asserted … that responsible states should retain the right to hold and modernize nuclear weapons, rights that should not be granted to evildoers.
As Krepon shows, such thinking has profoundly hurt nuclear non-proliferation efforts. If applied to biological non-proliferation efforts, it is likely to do the same. Krepon is right when he states that “[w]e are wise to distinguish responsible states from dangerous ones by comparing their actions against universal norms; we invite trouble by trying to impose different norms for friends and potential adversaries.”
Given the heady rhetoric, but lack of real attention to compliance issues, it is no surprise that the Review Conference did not agree on ways to improve mechanisms for investigating allegations of non-compliance. Nor did it even agree on measures to strengthen investigations of allegations of bioweapons use, or to update or strengthen the UN Secretary General’s investigation mechanism. The first was too much to expect, even for optimists. But the second should have been achievable.
So, what are we left with as outcomes of the Review Conference? In addition to agreeing to establish an ISU with a mandate to fulfill certain specific (and perhaps fairly broad) tasks, and to take steps to improve participation in the CBM mechanism, the States Parties agreed to undertake efforts to promote universalization of the treaty.
The other significant agreement was on the form and content of the annual meetings that will take place from 2007 – 2010. In terms of form, there will be a one week meeting of States Parties each year (two weeks in 2010, in anticipation of the Seventh Review Conference), prepared by a one week meeting of experts. In terms of content, the meetings will discuss the following topics:
In 2007:
Ways and means to enhance national implementation, including enforcement of national legislation, strengthening of national institutions and coordination among national law enforcement institutions.
Regional and sub-regional cooperation on BWC implementation.
In 2008:
National, regional and international measures to improve biosafety and biosecurity, including laboratory safety and security of pathogens and toxins.
Oversight, education, awareness raising, and adoption and/or development of codes of conduct with the aim to prevent misuse in the context of advances in bio-science and bio-technology research with the potential of use for purposes prohibited by the Convention.
In 2009:
With a view to enhancing international cooperation, assistance and exchange in biological sciences and technology for peaceful purposes, promoting capacity building in the fields of disease surveillance, detection, diagnosis, and containment of infectious diseases: (1) for States Parties in need of assistance, identifying requirements and requests for capacity enhancement, and (2) from States Parties in a position to do so, and international organizations, opportunities for providing assistance related to these fields.
In 2010:
Provision of assistance and coordination with relevant organizations upon request by any State Party in the case of alleged use of biological or toxin weapons, including improving national capabilities for disease surveillance, detection and diagnosis and public health systems.
As noted previously, certain pressing issues, such as transparency of biodefense activities, and investigations of non-compliance, are simply not included. Perhaps even more significantly, the annual meetings won’t be empowered to take binding decisions. This was one of the main weaknesses of the last round of annual meetings from 2003 – 2005, and one that many States Parties wanted to see corrected. Our understanding is that the United States was dead set against this idea, however. As the Arms Control Association’s Olivier Meier noted “over the next five years, discussions without decisions will not be enough to address the threat from bioterrorism and the lack of transparency.”
So, coming out of the Sixth Review Conference, we are left with a decidedly mixed bag. There is room for discussion, including of some relatively important topics. And there is the possibility of establishing an effective and useful, if limited, Implementation Support Unit. But there is no movement (and maybe even backwards movement) on the hard issues of (non-)compliance and resolving North-South tensions. And beyond the ISU, it is difficult to see how the BWC, and thereby efforts to prevent the development and use of biological weapons, has been strengthened.
For all of its bluster about non-compliance and national implementation, when it comes to concrete action, the United States has accomplished very little. Why is this so? I can only offer the following hypothesis, undoubtedly too simple, but perhaps a basis for further discussion: in the first case because efforts to address compliance would impinge on national sovereignty, and might call into question some US biodefense activities to boot. In the second case (and also the first?), because the current U.S. aversion to real diplomacy, and its disposition against universal norms, won out over the U.S. desire for real progress.